Cargando…

Nek2-targeted ASO or siRNA pretreatment enhances anticancer drug sensitivity in triple-negative breast cancer cells

Although the anticancer drugs paclitaxel and doxorubicin are commonly used to treat many solid tumors, their effectiveness is highly variable due to tumor cell resistance. Therefore, it is important to find mechanisms that can be targeted to increase the sensitivity of cancer cells to current chemot...

Descripción completa

Detalles Bibliográficos
Autores principales: LEE, JAEHYUNG, GOLLAHON, LAUREN
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3597451/
https://www.ncbi.nlm.nih.gov/pubmed/23340795
http://dx.doi.org/10.3892/ijo.2013.1788

Ejemplares similares